Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2015-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/17425255.2015.996546PMID 25539046PMCID PMC4428551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users

  2014cited by this paper
• Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men.

  2014cited by this paper
• Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

  2014cited by this paper
• Factors Related to Changes in CD4+ T-Cell Counts over Time in Patients Living with HIV/AIDS: A Multilevel Analysis

  2014cited by this paper
• Tobacco use among HIV-infected individuals in a rural community in Yunnan Province, China.

  2014cited by this paper
• Enhanced Methamphetamine Metabolism in Rhesus Macaque as Compared with Human: An Analysis Using a Novel Method of Liquid Chromatography with Tandem Mass Spectrometry, Kinetic Study, and Substrate Docking

  2014cited by this paper
• Cobicistat: a new opportunity in the treatment of HIV disease?

  2014cited by this paper
• Enhanced Nicotine Metabolism in HIV-1–Positive Smokers Compared with HIV-Negative Smokers: Simultaneous Determination of Nicotine and its Four Metabolites in Their Plasma Using a Simple and Sensitive Electrospray Ionization Liquid Chromatography–Tandem Mass Spectrometry Technique

  2014cited by this paper
• Enhanced methamphetamine metabolism in rhesus macaque as compared to human: An analysis using a novel LCMS/MS method, kinetic study, and substrate docking

  2014cited by this paper
• High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting

  2014cited by this paper
• Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms

  2014cited by this paper
• Opioid Analgesic Misuse is Associated with Incomplete Antiretroviral Adherence in a Cohort of HIV-Infected Indigent Adults in San Francisco

  2014cited by this paper
• Chronic ethanol use in alcoholic beverages by HIV-infected patients affects the therapeutic window of stavudine, lamivudine and nevirapine during the 9-month follow-up period: using chronic alcohol-use biomarkers

  2014cited by this paper
• New Antiretroviral Therapies and Potential Drug Interactions in HIVInfectedDrug Abusers

  2014cited by this paper
• Preliminary Evidence for Feasibility, Use, and Acceptability of Individualized Texting for Adherence Building for Antiretroviral Adherence and Substance Use Assessment among HIV-Infected Methamphetamine Users

  2013cited by this paper
• High Prevalence of Illicit Drug Use in Men Who Have Sex with Men with HIV-1 Infection in Japan

  2013cited by this paper
• Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.

  2013cited by this paper
• Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes

  2013cited by this paper
• The issues around opioid prescribing in HIV-related pain.

  2013cited by this paper
• Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications

  2013cited by this paper
• Intentional Non-Adherence to Medications among HIV Positive Alcohol Drinkers: Prospective Study of Interactive Toxicity Beliefs

  2013cited by this paper
• Bioavailability: A pharmaceutical review

  2013cited by this paper
• Aggregate Versus Day Level Association Between Methamphetamine Use and HIV Medication Non-adherence Among Gay and Bisexual Men

  2013cited by this paper
• Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway

  2013cited by this paper
• Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.

  2013cited by this paper
• Viral Suppression and Antiretroviral Medication Adherence Among Alcohol Using HIV-Positive Adults

  2013cited by this paper
• Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

  2013cited by this paper
• Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail

  2013cited by this paper
• The Effects of Psychostimulant Drugs on Blood Brain Barrier Function and Neuroinflammation

  2012influential reference
• Use of alcohol, nicotine and other drugs in the Western Australian HIV Cohort study.

  2012cited by this paper
• Receipt of Opioid Analgesics by HIV-Infected and Uninfected Patients

  2012cited by this paper
• HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS

  2012cited by this paper
• Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence

  2012cited by this paper
• Factors Associated with Nonadherence to Antiretroviral Therapy in HIV-Positive Smokers

  2012cited by this paper
• HIV-1, reactive oxygen species, and vascular complications.

  2012cited by this paper
• Influence of sex differences and gonadal hormones on cocaine addiction.

  2012cited by this paper
• Neurocognitive dysfunction in the highly active antiretroviral therapy era

  2012cited by this paper
• Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes

  2012cited by this paper
• Cytochrome P450 variations in different ethnic populations

  2012cited by this paper
• Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.

  2011cited by this paper
• Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14

  2011cited by this paper
• A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users.

  2011cited by this paper
• Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.

  2011cited by this paper
• Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs.

  2011cited by this paper
• Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

  2011cited by this paper
• Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals.

  2011cited by this paper
• Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

  2011cited by this paper
• Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.

  2011cited by this paper
• Methamphetamine toxicity and its implications during HIV-1 infection

  2011cited by this paper
• Nonmedical use of prescription opioids and pain in veterans with and without HIV

  2011cited by this paper
• Drug–drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition

  2010cited by this paper
• Impact of drug transporters on cellular resistance towards saquinavir and darunavir.

  2010cited by this paper
• Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

  2010cited by this paper
• Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings

  2010cited by this paper
• Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir.

  2010cited by this paper
• Stereoselectivity in the human metabolism of methamphetamine.

  2010cited by this paper
• The NSDUH report - HIV/AIDS and substance use

  2010cited by this paper
• Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

  2010cited by this paper
• Methamphetamine abuse, HIV infection, and neurotoxicity.

  2009cited by this paper
• Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006

  2009cited by this paper
• The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

  2009cited by this paper
• Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy.

  2009cited by this paper
• CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women.

  2009cited by this paper
• Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier

  2009influential reference
• Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

  2009cited by this paper
• Prevalence and Clinical Implications of Interactive Toxicity Beliefs Regarding Mixing Alcohol and Antiretroviral Therapies among People Living with HIV/AIDS

  2009cited by this paper
• Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.

  2009cited by this paper
• Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.

  2008cited by this paper
• The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.

  2008cited by this paper
• Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

  2008cited by this paper
• Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

  2007cited by this paper
• Cigarette Smoking among HIV+ Men and Women: Examining Health, Substance Use, and Psychosocial Correlates across the Smoking Spectrum

  2007cited by this paper
• The role of cytochrome P450 in antiretroviral drug interactions.

  2007cited by this paper
• Retention in care: a challenge to survival with HIV infection.

  2007cited by this paper
• The impact of illicit drug use and substance abuse treatment on adherence to HAART

  2007cited by this paper
• Motivational Interviewing and Cognitive-Behavioral Intervention to Improve HIV Medication Adherence Among Hazardous Drinkers: A Randomized Controlled Trial

  2007cited by this paper
• Determinants of the rate of nicotine metabolism and effects on smoking behavior

  2006cited by this paper
• Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study.

  2006cited by this paper
• METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13

  2005cited by this paper
• Increased Viral Replication in Simian Immunodeficiency Virus/Simian-HIV-Infected Macaques With Self-Administering Model of Chronic Alcohol Consumption

  2005cited by this paper
• Crack Cocaine Use and Adherence to Antiretroviral Treatment Among HIV-Infected Black Women

  2004cited by this paper
• Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.

  2004cited by this paper
• Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

  2003cited by this paper
• Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection

  2003cited by this paper
• Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.

  2003cited by this paper
• Impaired Virologic Response to Highly Active Antiretroviral Therapy Associated With Ongoing Injection Drug Use

  2003cited by this paper
• HIV treatment in drug abusers: impact of alcohol use

  2003cited by this paper
• Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

  2003cited by this paper
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone

  2002cited by this paper
• The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

  2002cited by this paper
• The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.

  2002cited by this paper
• Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

  2002cited by this paper
• Alcohol Use and HIV Pharmacotherapy

  2002cited by this paper
• Alcohol use and HIV infection in the HAART era.

  2001cited by this paper
• Cytochromes P450 and metabolism of xenobiotics

  2001cited by this paper
• Alcohol Use Can Result in Enhanced Drug Metabolism in HIV Pharmacotherapy

  2001cited by this paper
• The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.

  2001cited by this paper
• Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression.

  2000cited by this paper
• Variability in Activity of Hepatic CYP3A4 in Patients Infected with HIV

  2000cited by this paper
• Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

  1999cited by this paper

• Repeat Behavioral Counseling, With and Without Combination Nicotine Replacement Therapy, for Smoking Cessation Among People With HIV in South Africa.

  2026cites this paper
• Cannabis use is associated with a lower likelihood of presence of HIV drug resistance mutations in a retrospective cohort of adults with HIV

  2025cites this paper
• EcoHIV infection effects on cocaine seeking and neuroimmune responses in male mice depend on cocaine exposure pattern

  2025cites this paper
• Prevalence and factors associated with HIV viral rebound in individuals on ART: A systematic review study

  2025cites this paper
• EcoHIV Infection Modulates the Effects of Cocaine Exposure Pattern and Abstinence on Cocaine Seeking and Neuroimmune Protein Expression in Male Mice

  2024cites this paper
• The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system

  2024cites this paper
• The Impact of Drugs and Substance Abuse on Viral Pathogenesis—A South African Perspective

  2024cites this paper
• An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV)

  2024cites this paper
• Impact of Concurrent Exposure of Diabetic Male Sprague Dawley Rats to Alcohol and Combination Antiretroviral Therapy (cART) on Reproductive Capacity

  2023cites this paper
• Co-administration of alcohol and combination antiretroviral therapy (cART) in male Sprague Dawley rats: a study on testicular morphology, oxidative and cytokines perturbations

  2023cites this paper
• Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study

  2023cites this paper
• HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats

  2023cites this paper
• Luteolin Alleviates Oxidative Stress in Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke via Modulation of the TRPV1 and CYP2A13/NRF2 Signaling Pathways

  2023cites this paper
• Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV

  2023cites this paper
• Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam

  2023cites this paper
• Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.

  2023cites this paper
• Brain opportunistic infections and tumors in people living with HIV — still a challenge in efficient antiretroviral therapy era

  2023cites this paper
• Molecular Factors and Pathways of Hepatotoxicity Associated with HIV/SARS-CoV-2 Protease Inhibitors

  2023cites this paper
• Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study

  2022cites this paper
• Intranasal delivery of darunavir improves brain drug concentrations in mice for effective HIV treatment

  2022cites this paper
• Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

  2022cites this paper
• Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options

  2022cites this paper
• Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020

  2022influential citation
• HIV Tat and cocaine interactively alter genome-wide DNA methylation and gene expression and exacerbate learning and memory impairments

  2022cites this paper
• Incidence and factors associated with adverse drug reactions in a cohort of individuals starting dolutegravir or efavirenz

  2022influential citation
• Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020

  2022influential citation
• Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

  2022cites this paper
• Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir

  2022cites this paper
• Chemsex and antiretroviral prescribing in an HIV cohort in Brighton, UK

  2022cites this paper
• Cariprazine as an anti-impulsive treatment in a case series of patients with HIV and chemsex practices

  2022cites this paper
• Special Section on Drug Metabolism in Liver Injury and Repair Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells

  2022cites this paper
• Nicotine self-administration with menthol and audiovisual cue facilitates differential packaging of CYP2A6 and cytokines/chemokines in rat plasma extracellular vesicles

  2021cites this paper
• Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities

  2021cites this paper
• Development and evaluation of a booklet to promote ealthy lifestyle in people with HIV.

  2021cites this paper
• A Critical Review on Advancement in Analytical Strategies for the Quantification of Clinically Relevant Biological Transporters

  2021cites this paper
• Substance-Related and Addictive Disorders

  2021cites this paper
• Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells

  2021cites this paper
• Alterações farmacocinéticas de antirretrovirais em situações especiais: uma revisão narrativa

  2021cites this paper
• Potential drug‐drug interactions in acute poisonings managed in the intensive care unit: Occurrence, risk factors and relationship to patient severity on admission

  2021cites this paper
• Effectiveness of a group intervention to reduce sexual transmission risk behavior among MSM living with HIV: a non-randomized controlled pilot study

  2021cites this paper
• Cocaine exacerbates neurological impairments and neuropathologies in the iTat model of HIV-associated neurocognitive disorder through genome-wide alterations of DNA methylation and gene expression

  2021cites this paper
• Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain

  2021cites this paper
• Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study

  2021cites this paper
• Alterações farmacocinéticas de antirretrovirais em situações especiais: uma revisão narrativa

  2021cites this paper
• Predictors of Virological Failure after Adherence-Enhancement Counseling among First-Line Adults Living with HIV/AIDS in Kombolcha Town, Northeast Ethiopia

  2021cites this paper
• Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat.

  2021cites this paper
• Cell-based and cell-free firefly luciferase complementation assay to quantify Human Immunodeficiency Virus type 1 Rev-Rev interaction

  2021cites this paper
• Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury

  2020cites this paper
• Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives

  2020cites this paper
• Novel Phenethylamines and their Potential Interactions with Prescription Drugs: A Systematic Critical Review.

  2020cites this paper
• From bedside to bench and back : future options for antiretroviral drugs in non-B HIV-1 subtypes

  2020cites this paper
• Psychiatric Aspects of Coronavirus (2019-nCoV) Infection

  2020cites this paper
• Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges

  2020cites this paper
• An update on drug–drug interactions between antiretroviral therapies and drugs of abuse in HIV systems

  2020cites this paper
• Clinical impact of recreational drug use among people living with HIV in southern Taiwan.

  2020cites this paper
• Promoting Undetectable Equals Untransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence

  2020cites this paper
• Associations between methamphetamine use and lack of viral suppression among a cohort of HIV positive persons who inject drugs in hai phong vietnam.

  2020cites this paper
• Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.

  2020cites this paper
• High prevalence of recreational and illicit drug use in German people living with HIV with a potential for drug–drug interactions with antiretroviral therapy

  2020cites this paper
• An Innovative Physical Therapy Intervention for Chronic Pain Management and Opioid Reduction Among People Living with HIV

  2020cites this paper
• HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

  2019cites this paper
• Substance Use Among Older People Living With HIV: Challenges for Health Care Providers

  2019cites this paper
• Choosing the right pharmacotherapeutic strategy for HIV maintenance in patients with alcohol addiction

  2019cites this paper
• Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study

  2019cites this paper
• Adverse pharmacokinetic interactions between illicit substances and clinical drugs

  2019influential citation
• A New Era of HIV Risk: It's Not What You Know, It's Who You Know (and How Infectious).

  2019cites this paper
• Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV

  2019cites this paper
• Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy

  2019cites this paper
• Cocaine use modifies the association of antiretroviral therapy regimens with obesity in HIV-infected adults

  2019cites this paper
• Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy

  2019cites this paper
• Prevalence and patterns of illicit drug use in people living with HIV in Spain: A cross-sectional study

  2019cites this paper
• Cocaine use modifies the association between antiretroviral therapy and endothelial dysfunction among adults with HIV infection

  2019cites this paper
• Impact of tobacco smoke in HIV progression: a major risk factor for the development of NeuroAIDS and associated CNS disorders

  2019cites this paper
• Common mental disorders and psychological adjustment among individuals seeking HIV testing: a study protocol to explore implications for mental health care systems

  2018cites this paper
• Testing the Efficacy of Combined Motivational Interviewing and Cognitive Behavioral Skills Training to Reduce Methamphetamine Use and Improve HIV Medication Adherence Among HIV-Positive Gay and Bisexual Men

  2018cites this paper
• Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults

  2018cites this paper
• Effect of Comorbidities on HIV-1 Pathogenesis in Monocytic Cells

  2018cites this paper
• Substance use patterns among women living with HIV compared with the general female population of Canada.

  2018cites this paper
• Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers

  2018cites this paper
• Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV

  2018cites this paper
• Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatients

  2018cites this paper
• NeuroAIDS in Drug Abusers: Associations with Oral Manifestations

  2017cites this paper
• Role of Autophagy in HIV Pathogenesis and Drug Abuse

  2017cites this paper
• Étude sur la pratique du « Chemsex » au sein de la file active d’hommes ayant des relations sexuelles avec des hommes (HSH) vivant avec le VIH suivis au CHU de la Réunion

  2017cites this paper
• Efeito do álcool em pessoas com HIV: tratamento e qualidade de vida

  2017cites this paper
• Alcohol Screening and Brief Intervention for Persons Living with HIV

  2017cites this paper
• Endocrine disrupting effects of HIV antiretrovirals in the South African aquatic environment

  2017cites this paper
• Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men

  2017cites this paper
• HIV, Tat and dopamine transmission.

  2017cites this paper
• Dissecting the Role of Disturbed ER-Golgi Trafficking in Antivirals and Alcohol Abuse-Induced Pathogenesis of Liver Disorders

  2017cites this paper
• Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era

  2017cites this paper
• Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agents

  2017cites this paper
• Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

  2016cites this paper
• Clinical Features, Disease Modifiers, and Natural History of Alcoholic Liver Disease

  2016cites this paper
• Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease

  2016cites this paper
• Training and Practices of Cannabis Dispensary Staff

  2016cites this paper
• Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity.

  2016cites this paper
• Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.

  2016cites this paper
• Chronic health conditions in Medicare beneficiaries 65 years old, and older with HIV infection.

  2016cites this paper
• Chapter 4 – Application of Bioanalytical Methods to Assess Medication Adherence in Clinical Settings

  2016cites this paper